Guardian Pharmacy Q4 revenue up 20% to $338.6M; FY net loss $71M on IPO charges

Guardian Pharmacy Services, Inc.

Q4 revenue $338.6M (+20% YoY); resident count 186,000 (+14% YoY).
Q4 net income $11.8M (down $2.7M YoY); FY net loss $71.0M on $131.5M stock-comp from IPO/Reorg.
Adjusted EBITDA Q4 $25.9M (+30% YoY); FY $90.8M (+19% YoY).
No debt outstanding at year-end; $40M credit line available (expandable to $75M).
FY2025 guidance: revenue $1.33B-$1.35B, Adj. EBITDA $97M-$101M; incl. ~$4M public co. costs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.